FAYE M JOHNSON to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications FAYE M JOHNSON has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.072
-
Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC? Nat Rev Clin Oncol. 2009 Oct; 6(10):562-3.
Score: 0.072
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.